Description
• Accomplished in all stages of drug discovery from target selection to clinical nomination and first-in-human studies • Matrix team leader and collaborator in multidisciplinary teams with internal and external organizations • Assay development, biomarker discovery, and evaluation of preclinical and clinical drug candidates • Strong background in molecular biology, cellular and in vivo pharmacology, neurodegeneration • Writer of many scientific publications and coauthor on more than 40 papers Expertise includes assay development, biochemistry, biologics, genetics, in vitro, in vivo, molecular biology, neuroscience, pharmacology, small molecule mechanism, translational biomarker discovery, yeast genetics, and drug discovery for neurodegenerative diseases. Additional experience through collaborations includes: behavioral biology, due diligence, electrophysiology, genomics, high throughput screening, mass spectroscopy, medicinal chemistry, pharmaceutics, pharmacokinetics and metabolism, preclinical safety, proteomics, statistics, regulatory documentation and early clinical development.
Accomplishments
Highlights:
Keywords
